gilteritinib
Showing 26 - 29 of 29
Acute Myeloid Leukemia (AML), FMS-like Tyrosine Kinase-3 (FLT3) Mutations Trial in Australia, Italy, United Kingdom
No longer available
- Acute Myeloid Leukemia (AML)
- FMS-like Tyrosine Kinase-3 (FLT3) Mutations
- gilteritinib
-
Canberra, Australia
- +5 more
Sep 12, 2018
Acute Myeloid Leukemia Trial in Germany, Italy, United States (Gilteritinib, Voriconazole, Midazolam)
Completed
- Acute Myeloid Leukemia
- Gilteritinib
- +3 more
-
Birmingham, Alabama
- +25 more
May 9, 2019
Non-Small-Cell Lung Cancer Trial in Japan (Gilteritinib, Erlotinib)
Terminated
- Non-Small-Cell Lung Cancer
- Gilteritinib
- Erlotinib
-
Fukuoka Minami-ku, Fukuoka, Japan
- +3 more
Jan 21, 2019
Acute Myeloid Leukemia (AML) Trial in Japan (Gilteritinib)
Completed
- Acute Myeloid Leukemia (AML)
- Gilteritinib
-
Aichi, Japan
- +4 more
Dec 20, 2018